Concepedia

Bruno Bockorny

BB

23

Publications

1.5K

Citations

15

H-Index

2012

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

HonorHealth

Dana-Farber Cancer Institute

Agenus (United States)

Bruno Bockorny is an author at Beth Israel Deaconess Medical Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2012–2024

23

Publications

23

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

Bruno Bockorny, Valerya Semenisty, Teresa Macarulla et al. · Nature Medicine · 2020 · 501 citations

, , +8

Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression

Maria Rusan, Kapsok Li, Yvonne Li et al. · Cancer Discovery · 2017 · 140 citations · Full text

PDX-derived organoids model in vivo drug response and secrete biomarkers

Ling Huang, Bruno Bockorny, Indranil Paul et al. · JCI Insight · 2020 · 125 citations · Full text

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe et al. · Clinical Cancer Research · 2020 · 92 citations · Full text

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih et al. · Nature Medicine · 2024 · 79 citations · Full text

Rows per page

1–5 of 23